Inactive Instrument

News Guided Therapeutics Inc OTC Bulletin Board

Equities

US40171F3038

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results	Feb. 20	BU
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	Nov. 20	BU
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	Nov. 20	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval	23-05-01	BU
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K)	23-03-30	AQ
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation	23-03-15	BU
Guided Therapeutics, Inc. Announces CEO Changes	23-03-09	CI
Guided Therapeutics, Inc. Announces Executive Changes	23-03-09	CI
GUIDED THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)	23-03-09	AQ
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	22-12-21	BU
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	22-12-21	CI
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan	22-11-09	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Guided Therapeutics Inc OTC Bulletin Board

Equities

US40171F3038

Summary

Filters